Therapeutic potential of functionalized siRNA nanoparticles on regression of liver cancer in experimental mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic potential of functionalized siRNA nanoparticles on regression of liver cancer in experimental mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-01
DOI
10.1038/s41598-019-52142-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy
- (2016) Anish Babu et al. IEEE TRANSACTIONS ON NANOBIOSCIENCE
- Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
- (2016) Hea Oh et al. Nanomaterials
- Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
- (2015) Anisha A. D'Souza et al. JOURNAL OF CONTROLLED RELEASE
- MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma
- (2015) YE DONG et al. Molecular Medicine Reports
- Dendrimer-PLGA based multifunctional immuno-nanocomposite mediated synchronous and tumor selective delivery of siRNA and cisplatin: potential in treatment of hepatocellular carcinoma
- (2015) Mohd. Asif Sherwani et al. RSC Advances
- Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
- (2014) Yan Deng et al. GENE
- Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells
- (2014) Anish Babu et al. MOLECULAR PHARMACEUTICS
- Anticancer efficacy of a novel propofol–linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma
- (2013) Azmat Ali Khan et al. Nanomedicine
- Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy
- (2013) Jong-Min Lee et al. Biomed Research International
- PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells
- (2012) Wu-Chou Su et al. International Journal of Nanomedicine
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis and Characterization of Novel n-9 Fatty Acid Conjugates Possessing Antineoplastic Properties
- (2012) Azmat A. Khan et al. LIPIDS
- Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin
- (2011) Xiao-Bing Xiong et al. ACS Nano
- Simultaneous Delivery of siRNA and Paclitaxel via a “Two-in-One” Micelleplex Promotes Synergistic Tumor Suppression
- (2011) Tian-Meng Sun et al. ACS Nano
- Recent advances of siRNA delivery by nanoparticles
- (2011) Xudong Yuan et al. Expert Opinion on Drug Delivery
- Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma
- (2011) Meltem Baykara et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Polymers in Small-Interfering RNA Delivery
- (2011) Kaushik Singha et al. Nucleic Acid Therapeutics
- Survivin: The promising target in hepatocellular carcinoma gene therapy
- (2010) Jie Liu et al. CANCER BIOLOGY & THERAPY
- Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?
- (2010) R. S. Finn CLINICAL CANCER RESEARCH
- High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization
- (2010) Dongmei Cun et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines
- (2010) Vikas Jain et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
- (2010) A. P. Venook et al. ONCOLOGIST
- The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model
- (2009) Zhenghong Xu et al. BIOMATERIALS
- Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice
- (2009) R Zhang et al. CANCER GENE THERAPY
- Survivin: A new target for anti-cancer therapy
- (2009) Bríd M. Ryan et al. CANCER TREATMENT REVIEWS
- Preparation and characterization of poly(dl-lactide-co-glycolide) nanoparticles for siRNA delivery
- (2009) Dongmei Cun et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Survivin and Caspase-3 Expression in Breast Cancer: Correlation With Prognostic Parameters, Proliferation, Angiogenesis, and Outcome
- (2009) Aziza Nassar et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- New wirings in the survivin networks
- (2008) D C Altieri ONCOGENE
- Targeted Delivery of Macromolecular Drugs: Asialoglycoprotein Receptor (ASGPR) Expression by Selected Hepatoma Cell Lines used in Antiviral Drug Development
- (2008) Yan Li et al. Current Drug Delivery
- PLGA Nanoparticle−Peptide Conjugate Effectively Targets Intercellular Cell-Adhesion Molecule-1
- (2007) Na Zhang et al. BIOCONJUGATE CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started